One Comprehensive Universal Radiotherapy for Everyone (1-CURE) supports cross-disciplinary teams developing a single, low-cost radiotherapy treatment to eliminate local and metastatic tumors and prevent recurrence.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
Childhood Cancer Research Grants support investigators, including beginning scientists and physician-scientists, in targeted research to improve childhood cancer survival while protecting long-term health.
ACCESS Award supports researchers conducting clinical trials of affordable, scalable cancer interventions to improve treatment options and expand equitable access worldwide, especially in low-resource settings.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.